UPA | Retlira (Retatrutide) | 30mg Pen

RETLIRA 30MG PEN

Advanced Weight Management; Metabolic Reset

 What Is RETLIRA?

RETLIRA is a powerful triple-action peptide therapy containing 30mg of

Retratrutide, a new-generation weight loss compound targeting:

✅ GLP-1 receptors – reduces hunger; stabilizes blood sugar

✅ GIP receptors – improves insulin sensitivity

✅ Glucagon receptors – boosts fat burning & metabolism

RET LIRA mimics three key metabolic hormones in one weekly injection,

outperforming older GLP-1 options like Semaglutide and Tirzepatide.

✅ Why Choose RETLIRA (Retratrutide) Pen?

 High-strength Retratrutide – clinically backed for fat loss & glucose control

 Convenient pre-filled 30mg pen

 Ideal for those who’ve plateaued on Semaglutide or Tirzepatide

 Supports long-term appetite regulation, visceral fat loss, and insulin

improvement

 Used in cutting-edge obesity protocols

Triple action. One injection. Total transformation.

Active Ingredient Retratrutide 30mg per pen

Total Volume 3ml (10mg/ml)

Dosing Adjustable dial, 2.5mg–15mg per week

Injection Type Subcutaneous (abdomen, thigh, upper arm)

Use Frequency Once per week

Storage Refrigerate unopened (2–8°C). Use within 30 days once opened.

Format Prefilled, dial-dose pen (multi-week use)

➡️ One pen lasts 2 to 12 weeks, depending on dosage. Use once weekly on the same day each week.

DOSAGE CALCULATOR – RETRATRUTIDE 

Wee Suggested Volume to Dial (ml @ Effective Dose 10mg/ml)

1–2 2.5mg 0.25ml Intro phase – reduce nausea

3–4 5.0mg 0.5ml Appetite control begins

5–6 7.5mg 0.75ml Fat burn stage

7–8 10.0mg 1.0ml Full therapeutic level

9+ 12.5–15.0mg 1.25–1.5ml Maximum dose (if

tolerated)

Each 0.1ml = 1mg based on 10mg/ml concentration.